2022 SPEAKERS
Danjuma Adda, AMR Patient Alliance
Nicholas Adomakoh, Medical Director, Sandoz
Mark Albrecht, Branch Chief - Antibacterials Program, BARDA
Jose Alexander, Director of Microbiology, Virology, and Immunology, AdventHealth
Najy Alsayed, Global Therapeutic Area Head - Infectious Diseases Menarini Group, Menarini Group
Anand Anandkumar, Chief Executive Officer, Bugworks Research
James Anderson, Executive Director, Global Health, IFPMA
Phyllis Arthur, Vice President, Infectious Diseases and Emerging Science Policy, Biotechnology Innovation Organization (BIO)
Cristina Baker, Director of Medical Affairs, Cepheid
Mia Barnes, Senior Medical Science Liaison, Adaptive Biotechnologies
Daniel Bausch, Senior Director, Emerging Threats & Global Health Security President, FIND the global alliance for diagnostics
Xavier Becerra, Secretary, U.S. Department of Health & Human Services
Mohammed Benghezal, Global Project Lead in Anti-infectives,, Debiopharm
John Billington, Head of Commercial Pipeline & Health Security, Policy & Advocacy, GSK
Christopher Bland, Clinical Professor, University Of Georgia College Of Pharmacy
Gerald Bloom, Professorial Fellow, Institute of Development Studies
April Bobenchik, Medical Director Microbiology, Associate Professor Pathology, Penn State Hershey Medical Center
Katie Boland, Director of Business, Development, Immune Medicine,, Adaptive Biotechnologies
Robert Bollinger, Raj and Kamla Gupta Professor of Infectious Disease, The Johns Hopkins University School of Medicine
Maria Elena Bottazzi, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine
Abby Bownas, AVAC Manager and Partner, NVG LLC
Kyle Bozentko, Executive Director, Center for New Democratic Processes
Steve Brooks, Advisor, AMR Industry Alliance
Angella Browne, Infection Control Officer, Howard University Hospital
Ed Buurman, Director Alliances, CARB-X
Charles Cairns, Professor of Medicine and Emergency Medicine Senior Vice President, Medical Affairs, Drexel University College of Medicine
Kim Chapin-Robertson, Chief Medical Officer, Cepheid
Ricardo Chaves, Executive Medical Director Infectious Diseases, Debiopharm
Leonid Chindelevitch, Lecturer in Infectious Disease Epidemiology, Imperial College London
Ryan Cirz, CEO and Acting CSO, Revagenix, Inc.
Robin Cohen, Independent AMR Expert, Independent
Jennifer Cohn, Global Access Project Leader, Global Antibiotic Research & Development Partnership (GARDP)
Nick Conley, VP of Technology,, Locus Biosciences, Inc.
Sofia Côrte-Real, Scientific Advisor, Technophage
Alexandre Costa, Senior Health Advisor, UNICEF
Michael Craig, Senior Advisor For Antibiotic Resistance, Antibiotic Resistance Coordination And Strategy Unit, Centers for Disease Control and Prevention
Rachel Cumberbatch, Vice President, Regulatory and International Affairs, Animal health institute
Natalie D'Amore, Head of External Innovation, Seres Therapeutics Inc
Aleksandar Danilovski, Chief Scientific Officer, Xellia Pharmaceuticals
Matt Davis, Tele-stewardship pharmacist, Infectious Disease Connect
César De La Fuente, Presidential Assistant Professor, University of Pennsylvania
Robert Deluccia, Executive Chairman, Acurx Pharmaceuticals
Joël Denis, Director General, AMR Task Force, Public Health Agency Canada
Sarah Despres, Counselor for Public Health and Science, U.S. Department of Health & Human Services
Michele Dilizia, Vice President & Chief Scientific Officer,, Recce Pharmaceuticals
Elizabeth Dodds Ashley, Associate Professor of Medicine with the Division of Infectious Diseases and International Health, Duke University
Simon Doherty, Senior LEcturer, Queen’s University Belfast
Michael Dudley, President, Chief Executive Officer and Co-founder, Qpex Biopharma
Erin Duffy, Chief of Research & Development, CARB-X
Christian Eckmann, Head of Department of General, Visceral and Thoracic Surgery, Academic Hospital of Goettingen University
Aleks Engel, Director, REPAIR Impact Fund, Novo Holdings
Laureen Ferchaud, Head of Sales & Business Development, Molzym GmbH & Co. KG
Yann Ferrisse, Business Development Head, GARDP
David Findlay, Co Founder and Chief Executive Officer, Rostra Therapeutics
Cara Fiore, Senior Regulatory Scientist, FDA
Diane Flayhart, Global Public Health Program Lead,, BD
Vance Fowler, Professor of Medicine, Molecular Genetics and Microbiology,, Duke University
Greg Frank, Director global public policy, Merck
Dan Freedberg, Assistant Professor, Columbia University
Leonard Friedland, Vice President, GSK
Sean Gallagher, Senior Principal, IQVIA
Paul Garofolo, Chief Executive Officer, Locus Biosciences, Inc.
Valeria Gigante, Team Lead, World Health Organization
Marc Gitzinger, Vice President, BEAM Alliance
Jon Glaudemans, Executive Director of National Sepsis Data Trust Initiative, Sepsis Alliance
Debbie Goff, Infectious Diseases Specialist, College Of Pharmacy, Ohio State University Medical Center
Jaideep Gogtay, Chief Medical Officer, Cipla
Anna Govett, Programme Director, Future Leaders Against AMR
Vikas Gupta, Director, MMS Medical Affairs, BD
Dan Hackman, Chief Business Officer, Phlow Corporation
Celina Hanson, AMR Program Manager, UNICEF
Alwyn Hart, Lead Scientist, Environment Agency UK Government
Kathryn Hashey, Director, GSK
Martin Heidecker, Chief Investment Officer, AMR Action Fund
Moska Hellamand, Lead researcher in AMR, Access to Medicine Foundation
Matthew Henn, Chief Scientific Officer, Seres Therapeutics Inc
Thomas Heymann, President and CEO, Sepsis Alliance
Amanda Horstman-Smith, Science and Technology Manager, Defense Threat Reduction Agency
Susan Huang, Professor, University of California, Irvine
Peter Jackson, Executive Officer, Infex Therapeutics
John Jernigan, Chief, Epidemiology Research, and Innovations Branch, Centers for Disease Control and Prevention
Amanda Jezek, Senior Vice President, Public Policy And Government Relations, Infectious Diseases Society of America
Kris Johansen, Associate Director of External Relations, National Institute of Antimicrobial Resistance Research and Education (NIAMMRE)
Charley John, Director of Healthcare Policy & Strategy, Walgreen Co.
Melissa Johnson, Professor of Medicine and Liaison Clinical Pharmacist, Duke University Medical Center
Mark Jones, Head of Development, Basilea Pharmaceutica Ltd
Carriayne Jonesparr, Head of US Southeast Region, UK Science and Innovation Network
Mohan Joshi, Senior Principal Technical Advisor, USAID MTaPS
Robert Kadlec, Senior Counsel, U.S. Senate Health, Education, Labor and Pensions Committee
Mark Kazmierczak, Consultant to PACCARB, Gryphon Scientific
Steve Kearney, Global Medical Director, SAS
Denise Kelly, Advisor - Microbiome Expert, Seventure
Peter Kim, Director of the Division of Anti-Infectives, Food and Drug Administration (FDA)
Wes Kim, Director of Global Public Health Programs, American Society for Microbiology
Riko Kimoto, Senior Project Manager, Asia-Europe Foundation
Amy Kirby, Microbiologist, Waterborne Disease Prevention Branch Dfwed-Ncezid, CDC
Jeremy Knox, Head of Policy, Infectious Disease, Wellcome Trust
Akhila Kosaraju, Chief Executive Officer and President, Phare Bio
Jennifer L. Rakeman, Senior Director, Medical Affairs, Public Health Programs, Cepheid
Karim Lalji, Chief Executive Officer, Microbion Pharma Corp.
Christian Lillis, Co-founder and Executive Director, Peggy Lillis Foundation
Benjamin Liu, Assistant Prof. of Pathology, Pediatrics, George Washington University, Children's National Hospital
Syra Madad, Senior Director, System-wide Special Pathogens Program, NYC Health + Hospitals
Syra Madad, Infectious Disease Epidemiologist, Harvard Belfer Center for Science and International Affairs, Harvard Kennedy School
Shelley Magill, Division of Healthcare Quality Promotion, CDC
Walter Marlowe, Executive Director, Water Environment Federation (WEF)
Richard Marsden, Chief Executive Officer, Executive Director, Synairgen
Clifford Martin, Assistant Clinical Professor of Medicine, University of Arizona
Melina Mathur, Director of Product, Synthetic Biology & Biopharma, Twist Bioscience
Andrew McCabe, Chief Executive Officer, Association of American Veterinary Medical Colleges
Sarah McCClelland, Public Health Analyst, Depatment of Health and Human Service
Daniel Mcquillen, President, Infectious Diseases Society of America IDSA
Greg Merril, Chief Executive Officer, Adaptive Phage Therapeutics
Marc Meyer, Director of Pharmacy Services, Infection Control, Southwest Health System
Sheila Miknyoczki, Project officer, BARDA
Mary Millard, Patient Advocate, Sepsis Survivor
Melissa Mitchell, Secretariat Lead, AMR Industry Alliance
Gareth Morgan, Head, Global Portfolio Management and AMR Policy, Shionogi Pharma
Mirfin Mpundu, Director, React Africa
Bill Mudge, Director/ Co-Producer, Recombinant Films
Jean Mudge, Scriptwriter/ Co-Producer, Recombinant Films
Jomana Musmar, Senior Public Health Advisor, PACCARB
Tobi Nagel, President, Phages for Global Health
Mandy Nevel, Head of Animal Health and Welfare, Agriculture and Horticulture Development Board (ADHB)
Riccardo NIsato, Licensing and Grants Associate Manager, Debiopharm
Chime Nnadi, Head, US Vaccine Medical Affairs, Janssen
Lesley Ogilvie, Scientific Programme Officer, Global AMR R&D Hub
Deborah O'Neil, Chief Executive & Scientific Officer, NovaBiotics Ltd
Kevin Outterson, Professor, Boston University, Executive Director, CARB-X
Phil Packer, Innovation Lead AMR and Vaccines, Innovate UK
Javad Parvizi, Professor of Orthopaedic Surgery, Sidney Kimmel School of Medicine
Carmen Paun, Global Health Reporter, POLITICO
Carol Pearson, Health Reporter, Voice of America
Gabriel Pedone, Global Health Department, AMR Business Manager, bioMérieux
Jessica Petrillo, Senior Advisor for AMR and GHSA, U.S. Agency for International Developemnt
Paul Plummer, Executive Director, National Institute of Antimicrobial Resistance Research and Education (NIAMRRE)
Kavi Ramjeet, Head of Business Intelligence, FIND the global alliance for diagnostics
Brian Raux, Medical Science Liaison, bioMérieux
David Ripin, Executive Vice President of Infectious Diseases & Chief Science Officer, Clinton Health Access Initiative, Inc.
Tharini Sathiamoorthy, Director of Health Policy, Cepheid
Hatim Sati, Technical Officer, WHO AMR Global Coordination, World Health Organization
Mary Schaheen, President, Prevail Partners
Monika Schneider, Director, Global AMR Policy, Shionogi, Inc
Rick Sciotti, Chief, Drug Development Section, NIAID
Nandini Selvam, President, IQVIA Government Solutions
Diane Shader Smith, AMR Advocate and Author, -
Fei Shen, Investment Director, Boehringer Ingelheim Venture Fund
Dawn Sievert, Science Lead For Antimicrobial Resistance, Centers for Disease Control and Prevention
Henry Skinner, Chief Executive Officer, AMR Action Fund
Boumediene Soufi, Global Head AMR, Sandoz
Sarah Spitznogle, Transplant Infectious Diseases Clinical Pharmacist, UT Southwestern Medical Center
Anita Suresh, Deputy Director of Genomics & Sequencing Programme, FIND the global alliance for diagnostics
Karri Sutter, Scientific Director Medical Affairs, Infectious Diseases, Vaccines, U.S. Medical Affairs, Merck & Co., Inc.
Fred Tenover, Vice President Of Scientific Affairs, Cepheid
Alba Tiley, Head Global Sustainable Antibiotics Program, Centrient Pharmaceuticals
Glenn Tillotson, Consultant, Ferring Pharmaceuticals
Andrew Tomaras, Chief Scientific Officer, Forge Therapeutics
Maarten van der Heijden, Technical Officer, WHO
Monique Van Hoek, Professor School Of Systems Biology, George Mason University, College of Science
Marijn Verhoef, Director of Research and Operations, Access to Medicine Foundation
Rolf Wagenaar, Principal, CD&E Consulting LLC
Emily Wheeler, Director, Infectious Disease Policy, Biotechnology Innovation Organization (BIO)
Joanna Wieccek, Chief Scientific Officer, CircaGene
Hsiu Wu, Lead, NHSN Antimicrobial Use and Resistance team,, CDC
Kalvin Yu, Vice President Medical & Scientific Affairs, U.S. Region, BD
Milan Zdravkovic, CMO, Head of R&D, SNIPR BIOME
Angela Zhou, Information Scientist, American Chemical Society
Ghada Zoubiane, Head of Partnerships and Stakeholder Engagement, International Centre for AMR solutions
GET INVOLVED AT THE
WORLD ANTI-MICROBIAL RESISTANCE CONGRESS
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events